Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-01-25 @ 12:36 AM
Study NCT ID:
NCT00483366
Status:
COMPLETED
Last Update Posted:
2024-09-23
First Post:
2007-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
Sponsor:
University of Nebraska
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2009-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-06
First Submit QC Date:
None
Study First Post Date:
2007-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-20
Last Update Post Date:
2024-09-23
Last Update Post Date Type:
ACTUAL